 |
| Jan 31, 2012 - 12:14:49 PM |
2012 CCBFA Newsletter - Winter/Spring
Link to the 2012 Winter/Spring Association Newsletter.
Posted on: Jan 17, 2012 - 9:29:45 AM
FDA's Entry Review schedule for January 2012
CHICAGO FDA IMPORT ENTRY REVIEW SCHEDULE FOR JANUARY 2012
The FDA entry reviewers listed below will handle your entries transmitted to FDA electronically & manualLY for the month of January 2012.
January Entry Review Schedule:
Entry reviewer 1 Adam Taylor 001 - 336
Entry reviewer 2 Timothy Brennan 337 - 999
Entry reviewer 3 Tamara Qtami Letters A – J
Entry reviewer 4 Sherea Dillon Letters K - Z
FROM: FDA Chicago District Import Operations Group
TO: Import Trade Community
The purpose of this communication to remind the import trade community to HOLD FDA regulated cargo in the local port area when FDA Targets cargo for inspection in the following ports of entry 3901,3902,3906,3908,3909,3982,3995, and 3991.
Over the last year FDA Chicago District Import Operations has seen a spike in the movement of cargo out of the Chicago local area prior to FFDA inspection or release.
I want to emphasize the critical importance to the trade community; particularly import brokers/filers representing the importer of record by controlling the movement of cargo regulated by FDA. At this time electronic FDA Hold messages are sent solely to brokers/filers via CBP’s ABI and it is imperative that they communicate those FDA Hold message to importers, terminal operators etc. to prevent misdeliveries of FDA regulated cargo targeted for inspection. Releases issued under bond by CBP are conditionally released pending the admissibility determination of other government agencies. (FDA).
Customs and Border Protection (CBP) import bond regulations clarify the responsibilities of importers and FDA uses the terms and conditions in CBP’s import bond regulations (19 CFR 113.62) to maintain cargo control of goods FDA targets for inspection. CBP: If another government agency requires an inspection of the goods and they are not made available for the other agency activity, the CBP conditional release period is still ongoing until the goods are provided to FDA for inspection. If the goods are not available for inspection CBP can demand redelivery of the goods under the terms of the bond by issuing a Redelivery Notice consistent with 19 CFR 113.62(d). If the good are not redelivered for inspection, FDA will request CBP to pursue liquidated damages against the bond of the goods not re-delivered.
FDA ACTION
Effective immediately, for the above ports of entry. FDA Chicago District Import Operations Office will formally request CBP to demand redelivery (CBP Form 4647) of FDA regulated cargo when the cargo has been moved out of the Chicago local are prior to inspection or release.
Questions concerning these procedures may be directed to FDA Chicago District Import Program Manager Charles Spivey at 630 860-1307, ext, 1109.
Charles H. Spivey
U.S. Food and Drug Administration
Supervisory Consumer Safety Officer
1000 Tower Ln, Suite 190
Bensenville, IL 60106
Phone: (630)860-1307 ext. 1109
Fax: (630)860-5854
Posted on: Jan 31, 2012 - 12:10:51 PM
Port of Chicago Pipeline 12-02
Arrival Notices Required for Rail and Maritime Shipments
Posted on: Jan 26, 2012 - 1:59:34 PM
Port of Chicago Pipeline 12-01
New CBP Forms 301 and 301a, Customs Bonds
Posted on: Jan 5, 2012 - 10:46:01 AM
Port of Chicago Pipeline 11-23
Announcement of Centralized Examination Station Application Period and Selection Process for the Port of Rockford, Illinois.
Posted on: Jan 2, 2012 - 11:41:37 AM